Medicare Enrolled

Dr. Wandaly Pardo-Ruiz, M.D.

Hematology & Oncology · Oviedo, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
658 OVIEDO MEDICAL DR, Oviedo, FL 32765
4079019076
In practice since 2007 (18 years)
NPI: 1154525566 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pardo-Ruiz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pardo-Ruiz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pardo-Ruiz

Dr. Wandaly Pardo-Ruiz is a hematology & oncology specialist in Oviedo, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Pardo-Ruiz performed 28,996 Medicare services across 2,580 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pardo-Ruiz received a total of $3,481 from 27 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pardo-Ruiz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 20% volume in FL $3,481 industry payments

Medicare Practice Summary

Medicare Utilization ↗
28,996
Medicare services
Top 20% in FL for hematology & oncology
2,580
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,611 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 13,263 $0 $2
Contrast dye for imaging (iodine-based) 5,430 $0 $0
Denosumab injection (Prolia/Xgeva) 2,521 $18 $43
Dexamethasone injection (steroid) 856 $0 $1
Complete blood count (CBC) with differential 800 $8 $18
Blood draw (venipuncture) 742 $4 $4
Anti-nausea injection (Aloxi/palonosetron) 524 $1 $16
Comprehensive metabolic blood panel 497 $10 $29
Phosphate level test 484 $5 $15
Office visit, established patient (20-29 min) 447 $66 $219
Vitamin B-12 level test 336 $15 $43
Folic acid level test 334 $14 $42
Ferritin level test (iron stores) 329 $13 $39
Iron level test 326 $6 $18
Iron binding capacity test 325 $9 $24
Lactate dehydrogenase (enzyme) level 212 $6 $16
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 192 $22 $60
Drug injection, under skin or into muscle 173 $11 $76
Administration of chemotherapy into vein, 1 hour or less 121 $96 $415
Office visit, established patient (30-39 min) 113 $98 $321
Injection of drug or substance into vein 112 $28 $92
Hospital follow-up visit, high complexity 91 $93 $307
Injection of additional new drug or substance into vein 84 $12 $41
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 77 $45 $117
Carcinoembryonic antigen (cea) protein level 70 $19 $49
Initial hospital admission, high complexity 64 $130 $605
Administration of chemotherapy into vein, each additional hour 62 $22 $90
New patient office visit (45-59 min) 58 $125 $500
Ct scan of chest with contrast 56 $91 $979
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 52 $53 $123
CT scan of abdomen and pelvis with contrast 51 $166 $987
Nuclear medicine study from skull base to mid-thigh with ct scan 42 $1,107 $3,475
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 41 $402 $560
Injection, diphenhydramine hcl, up to 50 mg 40 $1 $2
PSA test (prostate cancer screening) 39 $18 $52
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 32 $20 $58
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.7% high complexity
34.9% medium
18.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,481
Total received (2018-2024)
Avg $696/year across 5 years
Bottom 46% in FL for hematology & oncology
27
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,481 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$133
2022
$215
2020
$20
2019
$693
2018
$2,420

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$760
Genentech USA, Inc.
$341
Novartis Pharmaceuticals Corporation
$217
Janssen Pharmaceuticals, Inc
$209
AstraZeneca Pharmaceuticals LP
$168
GENZYME CORPORATION
$168
Merck Sharp & Dohme Corporation
$165
Celgene Corporation
$162
Amgen Inc.
$147
Eli Lilly Export S.A. Puerto Rico Branch
$146
Novocure Inc.
$133
AbbVie, Inc.
$128
PFIZER PHARMACEUTICALS LLC
$109
Ipsen Biopharmaceuticals, Inc
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Eisai Inc.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$54
SANOFI-AVENTIS U.S. LLC
$47
Exelixis Inc.
$44
Puma Biotechnology, Inc.
$44
Clovis Oncology, Inc.
$40
PFIZER INC.
$40
MEDIVATION FIELD SOLUTIONS LLC
$40
Seattle Genetics, Inc.
$23
Agios Pharmaceuticals, Inc.
$22
EISAI INC.
$21
Incyte Corporation
$18
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Abraxane · Alecensa · Avastin · Blincyto · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · Erleada · FASLODEX · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LARTRUVO · LIBTAYO · LYNPARZA · Lenvima · NINLARO · Nerlynx · Neulasta · ONUREG · OPDIVO · Optune · PROMACTA · Perjeta · Revlimid · Rubraca · SOMATULINE DEPOT · SPRYCEL · SUTENT · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · XARELTO · XTANDI · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $12 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Oviedo?
Compare hematology & oncology specialists in the Oviedo area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
44
Per 100K population
9.3
County median income
$83,030
Nearest hospital
OVIEDO MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pardo-Ruiz is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pardo-Ruiz experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Pardo-Ruiz performed 13,263 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pardo-Ruiz receive payments from pharmaceutical companies?
Yes. Dr. Pardo-Ruiz received a total of $3,481 from 27 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pardo-Ruiz's costs compare to other hematology & oncology specialists in Oviedo?
Dr. Pardo-Ruiz's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pardo-Ruiz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →